- Stocks
- Consumer Defensive
- NASDAQ: CLXT

Price (delayed)

$0.2651

Market cap

$12.4M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.56

Enterprise value

$14.48M

Calyxt, based in Roseville, Minnesota, is a technology company with a mission to deliver plant-based innovations for a better world. Founded in 2010, Calyxt uses its proprietary TALEN® gene editing

The gross margin has soared by 79% YoY

CLXT's EPS is up by 47% year-on-year and by 13% since the previous quarter

The gross profit has dropped by 160% since the previous quarter but it has soared by 94% year-on-year

The quick ratio has grown by 41% from the previous quarter but it has contracted by 14% YoY

The company's revenue has shrunk by 72% YoY and by 55% QoQ

The equity has declined by 37% year-on-year and by 8% since the previous quarter

What are the main financial stats of CLXT

Market
Valuations
Earnings

Shares outstanding

46.79M

Market cap

$12.4M

Enterprise value

$14.48M

Price to earnings (P/E)

N/A

Price to book (P/B)

0.82

Price to sales (P/S)

1.27

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

1.48

Revenue

$9.78M

EBIT

-$21.72M

EBITDA

-$19.8M

Free cash flow

-$20.32M

Per share
Balance sheet
Liquidity

EPS

-$0.56

Free cash flow per share

-$0.44

Book value per share

$0.32

Revenue per share

$0.21

TBVPS

$0.69

Total assets

$32.02M

Total liabilities

$18.26M

Debt

$13.94M

Equity

$13.76M

Working capital

$8.36M

Debt to equity

1.01

Current ratio

2.86

Quick ratio

2.64

Net debt/EBITDA

-0.1

Margins
Efficiency
Dividend

EBITDA margin

-202.5%

Gross margin

-5.2%

Net margin

-229.8%

Operating margin

-271.2%

Return on assets

-61.1%

Return on equity

-153.3%

Return on invested capital

-67.5%

Return on capital employed

-79%

Return on sales

-222.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Calyxt stock price performed over time

Intraday

-3.98%

1 week

-2.79%

1 month

29.32%

1 year

-91.94%

YTD

-87.55%

QTD

9.77%

How have Calyxt's revenue and profit performed over time

Revenue

$9.78M

Gross profit

-$507,000

Operating income

-$26.52M

Net income

-$22.47M

Gross margin

-5.2%

Net margin

-229.8%

The gross profit has dropped by 160% since the previous quarter but it has soared by 94% year-on-year

The company's operating margin has shrunk by 154% YoY and by 128% QoQ

CLXT's net margin has plunged by 116% YoY and by 100% from the previous quarter

The gross margin has soared by 79% YoY

What is Calyxt's growth rate over time

What is Calyxt stock price valuation

P/E

N/A

P/B

0.82

P/S

1.27

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

1.48

CLXT's EPS is up by 47% year-on-year and by 13% since the previous quarter

The P/B is 84% below the 5-year quarterly average of 5.4 and 80% below the last 4 quarters average of 4.4

The equity has declined by 37% year-on-year and by 8% since the previous quarter

The stock's price to sales (P/S) is 100% less than its 5-year quarterly average of 476.1 and 45% less than its last 4 quarters average of 2.4

The company's revenue has shrunk by 72% YoY and by 55% QoQ

How efficient is Calyxt business performance

CLXT's return on sales has dropped by 117% year-on-year and by 103% since the previous quarter

The ROE has contracted by 21% YoY and by 3.2% from the previous quarter

The ROA has grown by 8% YoY

What is CLXT's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CLXT.

How did Calyxt financials performed over time

The total assets is 75% more than the total liabilities

The current ratio is up by 44% from the previous quarter but it is down by 18% YoY

The quick ratio has grown by 41% from the previous quarter but it has contracted by 14% YoY

The equity has declined by 37% year-on-year and by 8% since the previous quarter

CLXT's debt to equity is up by 23% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.